Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShawbrook Group Regulatory News (SHAW)

Share Price Information for Shawbrook Group (SHAW)

Share Price is delayed by 15 minutes
Get Live Data
323.00    -4.50 (-1.37%)
Bid:
320.50
Ask:
323.00
Spread: 2.50 (0.78%)
Market Cap: £1.68b
SHAW Live PriceLast checked at - London Stock Exchange

Intraday Shawbrook Group Share Chart

Shawbrook Q1 2026 Trading Update

14 May 2026 07:00

RNS Number : 2372E
Shawbrook Group PLC
14 May 2026
 

 

Shawbrook Group plc - Q1 2026 Trading Update

Shawbrook Group plc ('Shawbrook' or the 'Group') today issues its trading update for the three months ended 31 March 2026 ('Q1 2026') alongside guidance for FY26.

Q1 2026 highlights

 

31-Mar-2026

31-Dec-2025

Change

 

Loan book (including OTD)1

19.7bn

19.2bn

+2.6%

Customer deposits

18.7bn

18.4bn

+1.8%

CET1 ratio %

12.6

12.4

+0.2%

Total capital ratio %

14.9

14.8

+0.1%

3-month-plus arrears %

1.7

1.6

+0.1%

Marcelino Castrillo, Chief Executive Officer, commented:"Q1 2026 has delivered tangible progress against the strategic priorities we set out at the full year. Financial performance was strong in the first quarter, driven by continued growth and cost discipline. The loan book grew 2.6% in the quarter to £19.7 billion, with cost of deposits reducing to 3.71%. Asset quality remained robust and we strengthened our capital position by issuing £250 million of AT1 securities in April 2026.

 

We see attractive opportunities for growth within the specialist markets we serve, underpinned by a TAM of c.£300bn. Our proven specialist model and disciplined underwriting allow us to capture those opportunities, while remaining alert to the macroeconomic backdrop.

 

Our confidence underpins the FY26 guidance we are setting out today, as well as reiterating our medium-term guidance."

 

FY26 guidance 

We set out FY26 guidance below and reiterate the Group's medium-term guidance2.

Metric

FY26 guidance

 

Loan book (including OTD)

c.£21 billion

Cost to income ratio

<38%

CET1 ratio

>13.2% (pre-Basel 3.1)3

Underlying return on tangible equity

c.17%

Dividend policy

Maiden ordinary dividend in respect of FY26 results, payable in FY27

 

Strategic progress

Loan book (including OTD) increased to £19.7 billion (31 December 2025: £19.2 billion), supported by selective originations across our specialist segments and continued execution of our originate-to-distribute strategy.

Deposit balances increased to £18.7 billion (31 December 2025: £18.4 billion), with the stock cost of deposits reducing to 3.71% (FY 2025: 3.88%) and the cost of new retail funding aligned to our expectations.

Asset quality remained robust; 3-month-plus arrears4 were 1.7% (FY 2025: 1.6%), within management expectations.

CET1 ratio increased to 12.6% (31 December 2025: 12.4%)5. Capital generation in the quarter was in line with expectations and consistent with our trajectory toward the FY26 guidance range of >13.2% pre-Basel 3.1, reflecting the typical first-quarter step-up in operational risk-weighted assets.

Total capital ratio and AT1 issuance. In April 2026, we completed the issuance of a £250 million AT1 instrument in conjunction with a tender offer of the Group's existing £124 million AT1 securities. This increases the Group's total capital ratio from 14.9% to 16.0%, had the AT1 issue taken place as at 31 March 2026.

Originate-to-distribute. We disposed of our residual interest in the £510 million Lanebrook Mortgage Transaction 2024-1 as part of our OTD strategy.

ThinCats update. Following the Group's acquisition of ThinCats in Q4 2025, we completed the purchase of a c.£160 million loan portfolio, originated and serviced by ThinCats, further building scale in our targeted SME segment.

Footnotes:

1.

As at 31 March 2026, the Group's OTD balances increased to £1.8 billion, resulting in a loan book of £17.9 billion (December 2025: £17.8 billion).

2.

Medium-term guidance: Loan book growth of low double digits (based on a CAGR from FY24); Cost to income ratio of mid 30s; Underlying profit before tax growth of mid-high teens; Underlying return on tangible equity of high-teens; Maiden ordinary dividend in respect of FY26 results and a CET1 ratio of 12-13%.

3.

The CET1 ratio guidance includes the foreseeable dividend expected to be paid in 2027.

4.

The Group calculates its arrears measure by including all accounts that are greater than 3 contractual payments down at month end but excluding loans that are term expired. This is then divided by the total loan book, excluding term expired loans. ABL and Development Finance loans are excluded from the arrears measure given there is no concept of arrears in these products. Purchased or Originated Credit-Impaired loans are also excluded.

5.

Includes Bank of England levy of £2.6 million (Q1 2025: £2.5 million) and operational risk RWAs of £1,174 million (31 December 2025: £1,046 million), reflecting the annual recalibration of operational risk capital requirements effective 1 January 2026, equivalent to c.13bps of CET1. Total RWAs as at 31 March 2026 were £12,331 million (31 December 2025: £12,003 million).

 

For investor enquiries, please contact:

Murray Long

Head of Investor Relations

murray.long@shawbrook.co.uk

For further information, please contact:

Zander Swimburne

Teneo

shawbrook@teneo.com

 

About Shawbrook

Shawbrook is a UK bank providing specialist lending and savings products to consumers, SMEs and professional real estate investors. Our business model combines specialist lending expertise with a scalable, technology-enabled platform and disciplined credit underwriting. Shawbrook serves approximately 600,000 customers through its portfolio of brands. Shawbrook Group plc is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUOOWRNRUVAAR
Date   Source Headline
21st May 20264:12 pmRNSResult of AGM
21st May 20261:41 pmRNSResidential Mortgage-Backed Securities May 2026
14th May 20267:00 amRNSShawbrook Q1 2026 Trading Update
6th May 202610:29 amRNSTender Offer Results Announcement
5th May 20266:24 pmRNSRecent media coverage
28th Apr 20264:52 pmRNSSuccessful Pricing of £250 million AT1 Securities
27th Apr 20269:16 amRNSTender Offer Announcement - AT1 Securities
24th Apr 20264:04 pmRNSNotice of AGM
24th Apr 202612:41 pmRNSHolding(s) in Company
20th Apr 20263:10 pmRNSDirector/PDMR Shareholding
9th Apr 20264:25 pmRNSHolding(s) in Company
9th Apr 20264:19 pmRNSDirector/PDMR Shareholding
25th Mar 20262:52 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSShawbrook Full Year 2025 Results
12th Mar 20267:00 amRNSShawbrook Full Year 2025 Results
19th Feb 20265:00 pmRNSAppointment of Joint Corporate Brokers
14th Jan 20265:00 pmRNSDirector/PDMR Shareholding
8th Jan 20265:07 pmRNSDirector/PDMR Shareholding
16th Dec 20255:00 pmRNSDirector/PDMR Shareholding
4th Dec 20255:00 pmRNSResidential Mortgage-Backed Securities December 25
4th Dec 20257:00 amRNSInclusion in the FTSE 250 Index
28th Nov 20255:14 pmRNSShawbrook Group plc Post-Stabilisation Notice
28th Nov 20255:09 pmRNSExercise of Over-allotment Option
24th Nov 20255:27 pmRNSShawbrook Group plc Mid-Stabilisation Notice
13th Nov 20257:00 amRNSShawbrook Group plc Mid-Stabilisation Notice
13th Nov 20257:00 amRNSShawbrook Q3 2025 Trading Update
4th Nov 20251:16 pmRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSAdmission to trading on the London Stock Exchange
30th Oct 20257:00 amRNSAnnouncement of Pricing and Offer Size
9th Aug 20179:13 amRNSAdditional Listing
1st Aug 20173:49 pmRNSDate of cancellation of listing
1st Aug 20173:43 pmRNSTR-1 - Notification of Major Interest in Shares
27th Jul 201710:40 amRNSExercise of Options and Acceptance of Offer
26th Jul 201712:04 pmRNSExercise of Options and Acceptance of Offer
25th Jul 20173:31 pmRNSExercise of Options and Acceptance of Offer
19th Jul 20173:42 pmRNSCompulsory acquisition of Shawbrook shares
12th Jul 20175:00 pmRNSUpdate on Final Offer and Compulsory Acquisition
11th Jul 201711:30 amRNSPDMR Dealing - Amendment and Initial Notification
10th Jul 20172:58 pmRNSPDMR Dealing - Acceptance of the Offer
7th Jul 20176:16 pmRNSFinal offer declared unconditional in all respects
5th Jul 201711:05 amRNSNotification of Transactions of a PDMR
30th Jun 201710:27 amRNSForm 8.5 (EPT/NON-RI)
26th Jun 201710:19 amRNSTR-1: Notification of Major Interest in Shares
23rd Jun 201710:58 amRNSTR-1 - Notification of Major Interest in Shares
23rd Jun 20179:00 amRNSNotification of Transactions of PDMR
21st Jun 20175:42 pmRNSForm 8.3 - Shawbrook Group Plc
20th Jun 20173:20 pmRNSForm 8.3 - Shawbrook Group Plc
20th Jun 201711:43 amRNSForm 8.5 (EPT/RI)
20th Jun 201711:22 amRNSForm 8.5 (EPT/RI)
20th Jun 20179:36 amRNSForm 8.5 (EPT/RI) - Shawbrook Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.